Stereotactic body radiation therapy for low-, intermediate- and high-risk prostate cancer: Disease control and quality of life at 9 years

被引：3
|
作者：
Katz, Alan J.
Kang, Josephine
机构：
[1] Flushing Radiat, Flushing, NY USA
[2] Flushing Radiat Oncol, Flushing, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 02期
关键词：
D O I：
10.1200/jco.2016.34.2_suppl.20
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
20
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Stereotactic Body Radiation Therapy for Low-, Intermediate-, and High-Risk Prostate Cancer: Disease Control and Quality of Life at 6 Years
    Katz, A.
    Kang, J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S24 - S25
  • [2] Stereotactic Body Radiation Therapy for Low, Intermediate, and High-risk Prostate Cancer: Disease Control and Quality of Life
    Katz, A. J.
    Santoro, M.
    DiBlasio, F.
    Ashley, R.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S100 - S100
  • [3] Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer: Disease Control and Quality of Life at 8 Years
    Katz, A.
    Kang, J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E187 - E187
  • [4] Stereotactic Body Radiation Therapy for Localized Prostate Cancer: Risk Stratification for Intermediate- and High-Risk Patients
    Katz, A.
    Kang, J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E250 - E250
  • [5] Toxicity and Quality of Life After Hypofractionated Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer
    Seymour, Z. A.
    Chang, A.
    Roach, M.
    Gottschalk, A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S604 - S604
  • [6] Stereotactic Ablative Body Radiotherapy for Intermediate- or High-Risk Prostate Cancer
    Loblaw, Andrew
    [J]. CANCER JOURNAL, 2020, 26 (01): : 38 - 42
  • [7] Stereotactic body radiation therapy for low- and low-intermediate-risk prostate cancer: is there a dose effect?
    Katz, Alan J.
    Santoro, Michael
    Ashley, Richard
    Diblasio, Ferdinand
    [J]. FRONTIERS IN ONCOLOGY, 2011, 1
  • [8] Stereotactic Body Radiation Therapy for Low- to Intermediate-risk Prostate Adenocarcinoma
    Jeong, Bae-Kwon
    Jeong, Hojin
    Ha, In Bong
    Choi, Hoon Sik
    Kam, Sung Chul
    Hwa, Jeong Seok
    Hyun, Jae Seog
    Chung, Ky Hyun
    Choi, See Min
    Kang, Ki Mun
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2015, 30 (06) : 710 - 715
  • [9] Intermediate- to high-risk prostate cancer patient treated with radiation therapy
    Raben, David
    Lucia, Scott
    Glode, Michael
    Crawford, E. David
    Kavanagh, Brian
    Raben, Adam
    Ayres, Jennifer
    [J]. ONCOLOGY-NEW YORK, 2004, 18 (09): : 1105 - 1110
  • [10] A Pilot Study of Intensity Modulated Radiation Therapy with Hypofractionated Stereotactic Body Radiation Therapy (SBRT) Boost in the Treatment of Intermediate- to High-Risk Prostate Cancer
    Oermann, Eric K.
    Slack, Rebecca S.
    Hanscom, Heather N.
    Lei, Sue
    Suy, Simeng
    Park, Hyeon U.
    Kim, Joy S.
    Sherer, Benjamin A.
    Collins, Brian T.
    Satinsky, Andrew N.
    Harter, K. William
    Batipps, Gerald P.
    Constantinople, Nicholas L.
    Dejter, Stephen W.
    Maxted, William C.
    Regan, James B.
    Pahira, John J.
    McGeagh, Kevin G.
    Jha, Reena C.
    Dawson, Nancy A.
    Dritschilo, Anatoly
    Lynch, John H.
    Collins, Sean P.
    [J]. TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2010, 9 (05) : 453 - 462
12345